Literature DB >> 2832833

Enhancement of BOP-induced pancreatic carcinogenesis in selenium-fed Syrian golden hamsters under specific dietary conditions.

D F Birt1, A D Julius, C E Runice, L T White, T Lawson, P M Pour.   

Abstract

We measured the effects of dietary selenium (Se) on pancreatic cancer induced in Syrian golden hamsters by N-nitrosobis(2-oxopropyl)amine (BOP). The animals were fed six experimental diets that contained different combinations of the following: 0.1, 2.5, or 5.0 ppm Se from sodium selenite or 2.5 ppm Se from D,L-selenomethionine in either a low (6.0%)- or high (24.4%)-fat diet. Se treatment was begun four weeks before BOP treatment, and the high-fat diet was fed from one week after the last BOP treatment. No evidence for inhibition of pancreatic cancer by Se was observed; in fact, with some experimental conditions, high-Se diets increased the pancreatic carcinoma yield. However, the dietary conditions needed for enhancement differed between the sexes. The male hamsters that received the high-fat diet containing 2.5 ppm Se had more carcinomas than did males given the 0.1 ppm Se level. Carcinoma yields in females did not differ between these diets. Females that received 2.5 ppm Se from D,L-selenomethionine had a greater pancreatic carcinoma yield that did those given 0.1 ppm Se diet. However, carcinoma yields did not differ in males fed these diets. Acinar cell nodule yields were generally reduced in hamsters given the high-Se diets, especially when Se levels in the high-fat diets were compared. Prefeeding 0.1 or 2.5 ppm Se did not influence the elution constants of pancreatic DNA from ductal cells, indicating no effect of Se on the repair of BOP-induced, single-strand breaks in DNA from these cells. Measurements in acinar cells suggested a more rapid repair of single-strand breaks in hamsters prefed 2.5 ppm Se than in those prefed 0.1 ppm Se.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2832833     DOI: 10.1080/01635588809513966

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN: 0163-5581            Impact factor:   2.900


  8 in total

1.  Methylseleninic acid suppresses pancreatic cancer growth involving multiple pathways.

Authors:  Lei Wang; Hongbo Hu; Zhe Wang; Hua Xiong; Yan Cheng; Joshua Dezhong Liao; Yibin Deng; Junxuan Lü
Journal:  Nutr Cancer       Date:  2014-01-21       Impact factor: 2.900

2.  Null activity of selenium and vitamin e as cancer chemopreventive agents in the rat prostate.

Authors:  David L McCormick; K V N Rao; William D Johnson; Maarten C Bosland; Ronald A Lubet; Vernon E Steele
Journal:  Cancer Prev Res (Phila)       Date:  2010-02-09

Review 3.  Chemopreventive mechanisms of selenium.

Authors:  G F Combs
Journal:  Med Klin (Munich)       Date:  1999-10-15

4.  Inhibitory effect of selenium and change of glutathione peroxidase activity on rat glioma.

Authors:  Z H Zhang; M Kimura; Y Itokawa
Journal:  Biol Trace Elem Res       Date:  1996 Oct-Nov       Impact factor: 3.738

Review 5.  Environmental Selenium and Human Health: an Update.

Authors:  Marco Vinceti; Tommaso Filippini; Lauren A Wise
Journal:  Curr Environ Health Rep       Date:  2018-12

6.  Subchronic oral toxicity studies of Se-methylselenocysteine, an organoselenium compound for breast cancer prevention.

Authors:  W D Johnson; R L Morrissey; I Kapetanovic; J A Crowell; D L McCormick
Journal:  Food Chem Toxicol       Date:  2007-11-12       Impact factor: 6.023

Review 7.  Friend or foe? The current epidemiologic evidence on selenium and human cancer risk.

Authors:  Marco Vinceti; Catherine M Crespi; Carlotta Malagoli; Cinzia Del Giovane; Vittorio Krogh
Journal:  J Environ Sci Health C Environ Carcinog Ecotoxicol Rev       Date:  2013       Impact factor: 3.781

Review 8.  Selenium-Dependent Antioxidant Enzymes: Actions and Properties of Selenoproteins.

Authors:  Evangelos Zoidis; Isidoros Seremelis; Nikolaos Kontopoulos; Georgios P Danezis
Journal:  Antioxidants (Basel)       Date:  2018-05-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.